WallStSmart
NAUT

Nautilus Biotechnology Inc

NASDAQ: NAUT · HEALTHCARE · BIOTECHNOLOGY

$2.50
-3.47% today

Updated 2026-04-29

Market cap
$317.70M
P/E ratio
P/S ratio
EPS (TTM)
$-0.46
Dividend yield
52W range
$1 – $4
Volume
0.3M

Nautilus Biotechnology Inc (NAUT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+22.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+21.4%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.8%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+5.2%
2026-02-19
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-19$-0.11+29.0%$2.68$2.82+5.2%
2025-10-28$-0.11+26.7%$1.35$1.41+4.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.16$-0.11+29.0%
2025-09-30$-0.15$-0.11+26.7%
2025-06-30$-0.15$-0.12+20.0%
2025-03-31$-0.15$-0.13+13.3%
2024-12-31$-0.15$-0.14+6.7%$9.60M+16.9%
2024-09-30$-0.17$-0.13+23.5%
2024-06-30$-0.16$-0.14+12.5%
2024-03-31$-0.16$-0.15+6.3%
2023-12-31$-0.14$-0.14+0.0%$8.21M
2023-09-30$-0.17$-0.13+23.5%
2023-06-30$-0.15$-0.13+13.3%
2023-03-31$-0.17$-0.12+29.4%

Frequently asked questions

Has Nautilus Biotechnology Inc beaten earnings estimates?
Nautilus Biotechnology Inc has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +22.3% over the last 4 quarters.
How does NAUT stock react to earnings?
NAUT stock has moved an average of +4.8% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.